Navigation Links
Alzheimer's Disease Risk Factors May Be Gender-Specific
Date:5/1/2008

French study finds depression, stroke key factors in progression toward dementia

THURSDAY, May 1 (HealthDay News) -- Depression in women and stroke in men are critical factors in the development of Alzheimer's disease, French researchers report.

They analyzed data from almost 7,000 people over the age of 65 in three French cities. None of them had dementia, but about 40 percent had mild cognitive impairment at the start of the study.

They were assessed two and four years later. Of those with mild cognitive impairment at the start of the study, just over 6.5 percent developed dementia over the next four years, about half had no change, and about one-third regained normal levels of cognitive ability.

People with depression, those taking anticholinergic drugs (which influence chemical signaling in the brain), and those with a variation in the ApoE gene (a known risk factor for dementia) were more likely to progress from mild cognitive impairment to dementia.

The researchers also found that risk factors varied according to gender. Men with mild cognitive impairment were more likely to be overweight, diabetic and to have had a stroke. Men who'd suffered a stroke were almost three times more likely to progress from mild cognitive impairment to dementia.

Women with mild cognitive impairment were more likely to be in poorer general health, disabled, suffering from insomnia, and to have a poor support network. Women with depression were twice as likely to progress from mild cognitive impairment to dementia, while women unable to perform routine daily tasks (which would allow them to live without assistance) were 3.5 times more likely to progress to dementia.

Stroke was not a risk factor for women, even though both women and men had similar rates of stroke.

The study was published online in the Journal of Neurology Neurosurgery & Psychiatry.

More information'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Prozac Reduces Disease Activity in MS Patients
3. Salk study links diabetes and Alzheimers disease
4. High rate of complicated idiopathic gallstone disease in pediatric patients
5. How to manage Chinese obese children with non-alcoholic fatty liver disease?
6. Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
7. New treatment could reduce chronic lung disease in premature babies
8. Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nations No. 1 Killer
9. Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program
10. Transitioning patients with pediatric disease to adulthood
11. Investigators unveil new drug discovery tool for Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 1Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 1Next Generation Hemostatic Dressing Available for Military Emergencies 52198 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 3BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 1BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 3